Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...

Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...

No significant risks were seen for specific neuropsychiatric events individually or in any subgroup or sensitivity analysis, ...

Montelukast, a medication commonly prescribed for asthma and allergies, has come under increasing scrutiny due to its potential association with severe neuropsychiatric side effects, including ...

An asthma drug taken by hundreds of thousands of Australians could increase the risk of suicide, research suggests.

Use of montelukast not associated with risk of neuropsychiatric adverse events among children suggests a new study published in the JAMA.Spontaneous reports have indicated that ...

During the raids, the drug inspectors detained stocks of Montek-LC tablets ... The manufacturer also concluded that the batch of Montek-LC Tablets (Montelukast Sodium and Levocetirizine Hydrochloride ...

Results Among 1250 participants who were randomized and received the study drug or placebo, the median age was 53 years (IQR, 42-62 years), 753 (60.2%) were female, and 704 (56.3%) reported receiving ...